Navigation Links
Taiho Pharmaceutical ansöker om godkännande att tillverka och sälja det nya antitumörpreparatet TAS-102
Date:2/26/2013

TOKYO, 27 februari 2013 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. annonserade den 27 februari att man den 26 februari hade lämnat in en ansökan om godkännande för att tillverka och marknadsföra det nya perorala nukleosida antitumörpreparatet TAS-102 (en kombination av trifluorotymidin (FTD) och tipiracil-hydrochloride (TPI) ), till den japanska myndigheten för hälsovård, arbete och välfärd. Taiho Pharmaceutical söker godkännande av TAS-102 för indikationen icke-resektabel, avancerad, återkommande kolorektal cancer.

Ansökan om godkännande är baserad på resultaten från en klinisk fas II-studie (Studie 10040030) som genomförts vid 20 vårdinrättningar i hela Japan. Den var en randomiserad, dubbelblind jämförande studie mellan TAS-102 och placebo med 172 patienter med icke resektabel, avancerad, återkommande kolorektal cancer som var refraktär mot standardcytostatikabehandlingen som består av minst två behandlingsregimer innehållande fluoropyrimidin, irinotekan eller oxaliplatin. Resultaten visade att den grupp som fick TAS-102 hade en längre total överlevnad (medianvärde för total överlevnad: 9,0 månader gentemot 6,6 månader) och en signifikant minskad mortalitetsrisk (HR: 0,56, p=0,0011). Den vanligaste rapporterade läkemedelsbiverkningen med en CTCAE-grad på 3 eller högre var neutropeni. Förekomsten av diarré, trötthet, yrsel och andra biverkningar av grad 3 eller högre översteg ej 10 %. Taiho Pharmaceutical genomför för närvarande en global fas III-studie av TAS-102 hos en liknande patientpopulation med kolorektal cancer (RECOURSE) med den slutgiltiga målsättningen att preparatet ska godkännas och säljas i hela världen.

Taiho P
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
2. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
3. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
4. Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
5. Taiho Pharmaceutical presenta una solicitud para fabricar y comercializar el nuevo agente antitumoral TAS-102
6. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
7. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
8. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
9. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... WHITEHOUSE STATION, N.J. , Sept. 19, 2014 Merck ... the United States and Canada , ... on Desafiando La Diabetes: Logra Tus Metas , an educational ... of their blood sugar -- a key treatment goal to help ... the United States are at a higher risk for ...
(Date:9/19/2014)... Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy stores ... opened in Memphis and Cordova ... in Springfield on September 24 and a ... open October 22.  MinuteClinic is the largest and fastest growing provider ... . The Memphis -area clinics join ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... June 27 /CNW/ -,Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; ... a clinical trial,comparing CellCept (oral mycophenolate mofetil, MMF) ... of care, for,inducing treatment response in the induction ... rates were similar in both arms, the trial ...
... WIRE)--Jun 27, 2007 - PrimeCell(TM),Therapeutics LLC (http://www.primecelltherapeutics.com) ... pre-clinical,studies for a clinical trial to assess ... bone marrow stem cells into,spinal cord injury ... preliminary report at the 13th,Annual Meeting of ...
Cached Medicine Technology:Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for,Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical,Study 2
(Date:9/21/2014)... Young women starting college understand the benefits of a ... But they aren,t confident they can follow through on ... The study involved 268 female college freshmen ... and Eating Right program. The students answered food-related questions ... they were very busy with school work, were very ...
(Date:9/21/2014)... To accommodate the ever-growing customer base, Angeldress.co.uk decided to ... Recently, the company has unveiled its 2014 vintage ... wedding gowns, Angeldress.co.uk wants to make sure that all ... way. Its high quality vintage wedding outfits are now ... 62% off. , Online shopping is becoming more and ...
(Date:9/21/2014)... BambooIndustry.com, an experienced producer of natural bamboo items, has ... http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very popular ... discounted prices now, from 10 to 30 percent off. ... are available in many specifications; they are promised to ... finely manufactured by qualified workers. They are specially offered ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Top10BestSEOHosting.com, ... ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the most ... want to buy high quality hosting products. ... good hosting suppliers; we recommend two great hosting ... says, “We believe that iPage and GreenGeeks are ...
(Date:9/20/2014)... 6 Minutes to Skinny , a fat ... that is showing men and women of all ages how ... fat using simple 6-minute exercises and easy-to-follow lifestyle tips daily, ... review. , “When it comes to losing body fat, ... for all people,” reports Michaels. “Metabolism plays a big role ...
Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2
... use of narcotics for chronic pain in elderly works, ... the dose. On the other hand, the use of ... increase in the dosage with serious health repercussions. ... morphine, methadone and oxycodone. Opioid drugs are used for ...
... for creating stem cells that may be used to help ... lines are an exact match with the patients’ DNA and ... into using stem cells cloned from the persons to use ... first time human embryonic stem cells have been found suitable ...
... New study had found out that colonoscopy may be ... ,For patients suspected with colorectal cancer, flexible sigmoidoscopy ... of 1cm in diameter, adenomas with dysplasia, or cancer. ... neoplasia that may be cancerous for women who were ...
... may increase the risk of bacterial infection of the lungs, ... Medicine. ,Researchers had studied persons of age between 2 ... each of 635 persons with invasive pneumococcal disease, 10 persons ... defined by the study as proof of diagnosis of asthma ...
... among patients of colon cancer after undergoing surgery can reduce ... a study which was presented at the annual meeting of ... recurrence reduces by about 50% for the patients who took ... from colon cancer. ,Colon and rectum together form the ...
... Children suffering from Attention Deficit Hyperactivity Syndrome (ADHD) may ... help of sensory interventions like applying deep pressure or ... Hyperactivity Disorder (ADHD) is a condition that affects nearly ... early school years. Children with ADHD are known to ...
Cached Medicine News:
... Heavy Duty is a pressure relief mattress overlay ... specifically to the BariKare® Bed., ,INDICATIONS , ... lbs., Large patients at risk or suffering from ... mattress that would benefit from a pressure relief ...
... bariatric bed system which helps provide comfort ... care setting, ,INDICATIONS: ,Patients weighing up ... 2) ,Healthcare frame accommodating one or two ... ,CONTRAINDICATION: ,Total weight in excess of ...
... The BariMaxx™ is a full-featured healthcare ... environment for the care and management of ... up to 1000 lbs. ,Large patients at ... weight in excess of 1000 lbs. (including ...
EC+ Extra Care Bariatric Bed...
Medicine Products: